The lawsuit was filed in federal court in Pennsylvania. She says she used Lipitor to lower her levels of low-density lipoprotein (LDL) cholesterol and prevent heart disease from 2006-2012. She was diagnosed with type-2 diabetes in spring of 2013.
According to her complaint, her diagnosis of diabetes has put her “markedly increased risk of heart disease, blindness, neuropathy, and kidney disease.” She must take medication, adhere to a strict diet, and routinely test her blood-sugar levels.
Hoover is not alone in her complaint — over 464 Lipitor lawsuits are now pending in a federal Multi-District Litigation (MDL No. 2502) in the U.S. District Court for South Carolina. The litigation is overseen by Judge Richard M. Gergel.
Pfizer is accused of downplaying risk-information linking Lipitor to increases in blood-sugar levels, which could potentially cause type-2 diabetes. The U.S. Food and Drug Administration (FDA) ordered the company to provide safety warnings and update the label in February 2012. Unfortunately, by the time adequate warnings were in place, millions of people had used Lipitor.